SCHEMBL284861

SCHEMBL284861

CC(=O)C(CCCCN)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.56
RNPEP Q9H4A4 1/20 0.54
CPB2 Q96IY4 6/20 0.50
PAOX Q6QHF9 3/20 0.43
GABRR1 P24046 2/20 0.43
FOLH1 Q04609 1/20 0.42
CYP2D6 P10635 1/20 0.41
NFKB1 P19838 1/20 0.41
BLM P54132 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
PLG P00747 1/20 0.39
LMNA P02545 1/20 0.39
THRB P10828 1/20 0.39
ALOX15 P16050 1/20 0.39
SLC6A2 P23975 1/20 0.39
RECQL P46063 1/20 0.39
SLC6A3 Q01959 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19816432 0.98 GSR (0.54) GSRRNPEPCPB2PAOXGABRR1
SCHEMBL1426406 0.93 CPB2 (0.48) GSRRNPEPCPB2PAOXGABRR1
SCHEMBL12851375 0.88 GPR84 (0.41) GSRRNPEPBLMSLC6A3
SCHEMBL6922740 0.85 GPR84 (0.44) GSRCPB2SLC6A3
SCHEMBL1807063 0.85 GSR (0.65) GSRRNPEPCPB2GABRR1FOLH1
SCHEMBL15869673 0.83 GSR (0.62) GSRRNPEPCPB2PAOXGABRR1
SCHEMBL15869565 0.83 GSR (0.62) GSRRNPEPCPB2PAOXGABRR1
SCHEMBL15869626 0.83 GSR (0.62) GSRRNPEPCPB2PAOXGABRR1
SCHEMBL7457362 0.83 GSR (0.62) GSRRNPEPCPB2PAOXGABRR1
SCHEMBL6241890 0.83 PAOX (0.42) GSRRNPEPCPB2PAOXGABRR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12577594-B2 Engineered microorganisms and methods for improved aldehyde dehydrogenase activity GENOMATICA, INC. (US) 2026-03-17 US disclosed
US-20260028651-A1 METHOD OF PRODUCING & PROCESSING DIAMINES AGAIN BIO APS (DK) 2026-01-29 US disclosed
US-12503711-B2 Method of producing and processing diamines to a diamine free base using a carbonate intermediate and an engineered microorganism GENOMATICA, INC. (US) 2025-12-23 US disclosed
US-20250305013-A1 Methods and Compositions for Making Amide Compounds GENOMATICA, INC. (US) 2025-10-02 US disclosed
US-20240294885-A1 ENGINEERED ENZYMES AND METHODS OF MAKING AND USING AGAIN BIO APS (DK) 2024-09-05 US disclosed
EP-4423259-A1 ENGINEERED ENZYMES AND METHODS OF MAKING AND USING Genomatica, Inc. (US) 2024-09-04 EP disclosed
CN-118339281-A Engineered enzymes and methods of making and using the same 基因组股份公司 2024-07-12 CN disclosed
US-20240182935-A1 METHOD OF PRODUCING & PROCESSING DIAMINES AGAIN BIO APS (DK) 2024-06-06 US disclosed
US-11834690-B2 Microorganisms and methods for the biosynthesis of adipate, hexamethylenediamine and 6-aminocaproic acid GENOMATICA, INC. (US) 2023-12-05 US disclosed
EP-4277976-A1 METHODS AND COMPOSITIONS FOR MAKING AMIDE COMPOUNDS Genomatica, Inc. (US) 2023-11-22 EP disclosed
US-20130303723-A1 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID AGAIN BIO APS (DK) 2013-11-14 US disclosed
US-8377680-B2 Microorganisms and methods for the biosynthesis of adipate, hexamethylenediamine and 6-aminocaproic acid GENOMATICA, INC. (US) 2013-02-19 US disclosed
WO-2012177721-A1 MICROORGANISMS FOR PRODUCING 6-AMINOCAPROIC ACID GENOMATICA, INC. (US) 2012-12-27 WO disclosed
US-20120282661-A1 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID GENOMATICA, INC. (US) 2012-11-08 US disclosed
WO-2012038333-A2 COMPOSITION TO ACT IN PREVENTION AND TO TAKE CARE OF DIABETIC FOOT CLOSED STOCK COMPANY "INSTITUTE OF APPLIED NANOTECHNOLOGY" (RU) 2012-03-29 WO disclosed
EP-2427544-A1 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID Genomatica, Inc. (US) 2012-03-14 EP disclosed
US-20100317069-A1 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID AGAIN BIO APS (DK) 2010-12-16 US disclosed
WO-2010129936-A1 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID GENOMATICA, INC. (US) 2010-11-11 WO disclosed
US-7288372-B2 Methods for the preparation of chemically misaminoacylated tRNA via protective groups AMBERGEN, INC. (US) 2007-10-30 US disclosed
CN-86107574-A Compositions containing penem or carbapenem antibiotics and their use 1987-05-20 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12577594-B2 Engineered microorganisms and methods for improved aldehyde dehydrogenase activity ACADM, ALDH7A1, ADSL GSR 1242/4885RNPEP 853/4885CPB2 1449/4885
US-20260028651-A1 METHOD OF PRODUCING & PROCESSING DIAMINES DDC, DAO, ODC1 GSR 2365/4885RNPEP 1159/4885CPB2 1802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.